Buchi J Kevininsider trades
In SEC Form 4 filings, Buchi J Kevin is listed as Director of Amneal Pharmaceuticals, Inc. (AMRX). Buchi J Kevin reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 21.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| AMRXAmneal Pharmaceuticals, Inc. | Director | 3 | Sep 21 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-14
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| AMRXAmneal Pharmaceuticals, Inc. | Sep 17 | Sep 21 | G | 20,445 | $0.00 | $0 | 75,077 | No | Form 4 |
| AMRXAmneal Pharmaceuticals, Inc. | Sep 11 | Sep 14 | M | 20,445 | $14.45 | $295,430 | 95,522 | No | Form 4 |
| AMRXAmneal Pharmaceuticals, Inc. | Sep 11 | Sep 14 | M · derivative | 20,445 | $14.45 | $295,430 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.